
Integra LifeSciences Holdings Corporation IART
$ 13.38
1.75%
Quarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Operating Cash Flow 2011-2026 | IART
Annual Operating Cash Flow Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 M | 140 M | 264 M | 312 M | 204 M | 231 M | 200 M | 115 M | 116 M | 105 M | 83.6 M | 53.3 M | 59.1 M | 104 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 312 M | 53.3 M | 151 M |
Quarterly Operating Cash Flow Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -11.3 M | - | - | 15.8 M | - | - | 26.2 M | - | 179 M | - | 44.3 M | - | 243 M | - | 69.1 M | - | 124 M | 53.9 M | 20.8 M | - | 142 M | 78 M | 29.5 M | - | 157 M | 77.7 M | 41.5 M | - | 103 M | 57.8 M | 28.9 M | - | 110 M | 63.1 M | 25 M | - | 79.2 M | 59.6 M | 31.6 M | - | 58.7 M | 27.6 M | 11.3 M | - | 41.6 M | 10.8 M | 7.85 M | - | 62.5 M | 34.6 M | 32.3 M | - | 69.6 M | 45.8 M | 21.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 243 M | -11.3 M | 61.4 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
4.54 M | $ 34.1 | 3.49 % | $ 1.51 B | ||
|
Abiomed
ABMD
|
275 M | - | - | $ 17.2 B | ||
|
Boston Scientific Corporation
BSX
|
3.44 B | $ 100.0 | 1.37 % | $ 147 B | ||
|
Alphatec Holdings
ATEC
|
-44.7 M | $ 23.09 | 5.1 % | $ 3.3 B | ||
|
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
-5.25 M | $ 3.43 | -0.87 % | $ 119 M | ||
|
Cognyte Software Ltd.
CGNT
|
46.8 M | $ 9.52 | -0.23 % | $ 684 M | ||
|
Bio-Rad Laboratories
BIO
|
455 M | $ 318.95 | -1.6 % | $ 9 B | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
251 M | $ 52.28 | -1.38 % | $ 7.79 K | ||
|
CONMED Corporation
CNMD
|
167 M | $ 44.18 | 1.75 % | $ 1.36 B | ||
|
Abbott Laboratories
ABT
|
8.56 B | $ 127.39 | 0.28 % | $ 222 B | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | $ 3.72 | -2.11 % | $ 139 M | ||
|
Electromed
ELMD
|
11.4 M | $ 29.06 | -0.27 % | $ 246 M | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
-20.8 M | - | -0.97 % | $ 54.4 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
InMode Ltd.
INMD
|
133 M | $ 14.63 | -6.49 % | $ 1.16 B | ||
|
IRadimed Corporation
IRMD
|
25.6 M | $ 99.06 | 0.73 % | $ 1.26 B | ||
|
IRIDEX Corporation
IRIX
|
-6.74 M | $ 1.18 | -0.84 % | $ 19 M | ||
|
Align Technology
ALGN
|
738 M | $ 170.76 | 2.37 % | $ 12.8 B | ||
|
Accuray Incorporated
ARAY
|
2.86 M | $ 0.89 | 1.99 % | $ 91.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-27 M | $ 18.89 | 2.72 % | $ 436 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-8.95 M | $ 15.41 | 0.78 % | $ 416 M | ||
|
FONAR Corporation
FONR
|
15.3 M | $ 18.54 | - | $ 122 M | ||
|
LENSAR
LNSR
|
-2.28 M | $ 11.81 | 2.43 % | $ 136 M | ||
|
Globus Medical
GMED
|
521 M | $ 95.52 | 5.51 % | $ 13 B | ||
|
LivaNova PLC
LIVN
|
183 M | $ 65.28 | 1.02 % | $ 3.54 B | ||
|
Aziyo Biologics
AZYO
|
-21.8 M | - | 1.37 % | $ 20.5 M | ||
|
Establishment Labs Holdings
ESTA
|
-58.5 M | $ 71.53 | 2.16 % | $ 2.01 B |